Swine flu is infection of the respiratory system caused by influenza viruses. These viruses also infect the respiratory system of pigs causing barking cough, decrease in appetite, nasal secretions, and listless behavior. Influenza viruses can also be transmitted to humans. Swine flu viruses can induce genetic changes or mutations so that these are easily transmissible among humans. In April 2009, swine flu outbreak was first detected in Mexico and was caused due to the H1N1 virus.
Symptoms of swine flu infection in humans are similar to influenza infection; these include cough, nasal secretions, headache, fatigue, and fever (temp. 100 °F or higher). The gestation period of the disease is around one to four days. Swine flu can be transmitted from the day before the signs develop and can also transmit within five to seven days after signs develop. Some patients might be able to transmit for an extended time span. The disease lasts for about three to seven days, while severe infections could last for nearly nine to ten days. Vaccination is the best way to prevent the disease.
Influenza vaccine makes a significant division of global vaccine market. Rising awareness about influenza A (swine flu, H1N1) epidemic in 2009 and rise in health responsiveness in developing nations have played an important role in identifying the dynamics of the global influenza market. Trivalent flu vaccine protect against influenza B (H3N2) and influenza A viruses (H1N1). After Trivalent flu vaccine quadrivalent vaccines offered, which comprise two influenza B strains along with the standard two influenza A strains (H3N2 and H1N1). The two influenza B strains offer safety against both types of B families, which spread in varying proportions. The quadrivalent flu vaccine is developed to defend against four unlike flu viruses, for two influenza A viruses and two influenza B viruses, comprised one influenza B virus, an influenza A H3N2 virus, and an influenza A H1N1 virus. The research scientists in the novel study were capable to formulate a vaccine which formed antibodies from the stem cells. These vaccines were successful among diverse laboratory animals including monkeys, ferrets, and mice and secured against flu strains like H1N1 (swine flu) and H5N1 avian flu. Scientists are a step closer to develop a common flu vaccine to defend against all strains of the virus.
Governmental initiatives and increase in awareness about swine flu are the major drivers of the swine flu vaccine market. This is expected to encourage market players to gain a better understanding of the regulatory framework, product pricing, marketing, technological innovations, and market dynamics.
The global swine flu vaccine market can be segmented based on type of delivery device, route of administration, end-user, and region. In terms of type of delivery device, the global swine flu vaccine market can be classified into syringes, jet injectors, and other devices. Based on route of administration, the global swine flu market can be categorized into intradermal vaccination, intramuscular vaccination, subcutaneous vaccination, and other vaccinations. In terms of end-user, the market can be divided into hospital pharmacies, retail pharmacies, online pharmacies, and clinic & vaccination centers. Based on region, the global global swine flu vaccine market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Key players operating in the global swine flu vaccine market are Novartis AG, CSL Limited, Zydus Cadila, AstraZeneca plc, Medimmune, GlaxoSmithKline plc. , Sanofi SA, Baxter, and Sinovac Biotech Ltd.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.